.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Cipla
Healthtrust
Chubb
Novartis
Merck
Medtronic
Daiichi Sankyo
US Army
UBS

Generated: July 24, 2017

DrugPatentWatch Database Preview

Valacyclovir hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for valacyclovir hydrochloride and what is the scope of valacyclovir hydrochloride patent protection?

Valacyclovir hydrochloride
is the generic ingredient in two branded drugs marketed by Apotex Inc, Jubilant Generics, Dr Reddys Labs Ltd, Wockhardt, Mylan Pharms Inc, Cipla Ltd, Hetero Labs Ltd V, Teva Pharms, West-ward Pharms Int, Mylan, Watson Labs Inc, Sandoz, Aurobindo Pharma, Glaxosmithkline, and Sun Pharm Inds Ltd, and is included in fifteen NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Valacyclovir hydrochloride has one hundred and two patent family members in forty-five countries.

There are twenty-two drug master file entries for valacyclovir hydrochloride. Forty-seven suppliers are listed for this compound.

Summary for Generic Name: valacyclovir hydrochloride

Tradenames:2
Patents:3
Applicants:15
NDAs:15
Drug Master File Entries: see list22
Suppliers / Packagers: see list47
Bulk Api Vendors: see list80
Clinical Trials: see list2,330
Patent Applications: see list5,659
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:valacyclovir hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Inc
VALACYCLOVIR HYDROCHLORIDE
valacyclovir hydrochloride
TABLET;ORAL090370-002Mar 16, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Jubilant Generics
VALACYCLOVIR HYDROCHLORIDE
valacyclovir hydrochloride
TABLET;ORAL201506-001Apr 3, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Ltd
VALACYCLOVIR HYDROCHLORIDE
valacyclovir hydrochloride
TABLET;ORAL076588-001Jan 31, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
VALACYCLOVIR HYDROCHLORIDE
valacyclovir hydrochloride
TABLET;ORAL078518-002May 24, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Ltd
VALACYCLOVIR HYDROCHLORIDE
valacyclovir hydrochloride
TABLET;ORAL079012-001May 24, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: valacyclovir hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline
VALTREX
valacyclovir hydrochloride
TABLET;ORAL020487-001Jun 23, 1995► Subscribe► Subscribe
Glaxosmithkline
VALTREX
valacyclovir hydrochloride
TABLET;ORAL020487-002Jun 23, 1995► Subscribe► Subscribe
Glaxosmithkline
VALTREX
valacyclovir hydrochloride
TABLET;ORAL020487-002Jun 23, 1995► Subscribe► Subscribe
Glaxosmithkline
VALTREX
valacyclovir hydrochloride
TABLET;ORAL020487-001Jun 23, 1995► Subscribe► Subscribe
Glaxosmithkline
VALTREX
valacyclovir hydrochloride
TABLET;ORAL020487-002Jun 23, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: valacyclovir hydrochloride

Country Document Number Estimated Expiration
European Patent Office0804436► Subscribe
China1179100► Subscribe
World Intellectual Property Organization (WIPO)9622082► Subscribe
Norway315558► Subscribe
Mexico9705459► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Healthtrust
Covington
Dow
Deloitte
US Army
Daiichi Sankyo
Julphar
Cerilliant
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot